Managing stable COPD in 2009: incorporating results from recent clinical studies into a goal-directed approach for clinicians.
Chronic obstructive pulmonary disease (COPD) is prevalent in primary care practice and an important cause of functional decline, hospitalizations, and death. Recent clinical trials of COPD therapy demonstrate the ability of bronchodilators (especially long-acting beta2-agonists and anticholinergics), either alone or in combination with inhaled corticosteroids, to achieve the goals of managing stable disease. These management goals include: symptom relief, improvement in exercise tolerance and health status, prevention of exacerbations and progression of disease, and reduction in mortality. Recent studies of COPD treatment also provide important safety information to help clinicians address patient concerns about treatment risks. We reviewed recent clinical trials to develop concepts of care for the non-specialist clinician managing patients with stable COPD.
Rubins
Jeffrey B
JB
Minneapolis Veterans Affairs Medical Center, Minneapolis, MN, USA. rubin004@umn.edu
Raci
Erin
E
Kunisaki
Ken M
KM
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D006040:Goals; D006801:Humans; D029424:Pulmonary Disease, Chronic Obstructive / Q000175:diagnosis* / Q000188:drug therapy* / Q000503:physiopathology; D016032:Randomized Controlled Trials as Topic; D012720:Severity of Illness Index; D013147:Spirometry
D000305:Adrenal Cortex Hormones; D001993:Bronchodilator Agents